PROCEPT BioRobotics Corporation PRCT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $322.02M+29.3% | $308.05M+37.2% | $299.91M+50.1% | $274.95M+55.7% | $249.12M+59.4% | ||
| $116.01M+24.9% | $111.83M+28.0% | $106.32M+24.8% | $98.46M+23.2% | $92.9M+27.7% | ||
| $206.01M+31.9% | $196.23M+43.1% | $193.59M+68.8% | $176.49M+82.6% | $156.23M+86.9% | ||
| 64%+1.3pp | 63.7%+2.6pp | 64.5%+7.2pp | 64.2%+9.5pp | 62.7%+9.2pp | ||
| $76.34M+16.3% | $71.28M+14.4% | $67.29M+9.0% | $65.75M+16.0% | $65.62M+29.2% | ||
| $238.7M+27.6% | $228.81M+33.5% | $218.83M+37.3% | $202.51M+35.4% | $187.01M+32.4% | ||
| $315.04M+24.7% | $300.09M+28.4% | $286.11M+29.4% | $268.25M+30.0% | $252.63M+31.6% | ||
| $315.04M+24.7% | $300.09M+28.4% | $286.11M+29.4% | $268.25M+30.0% | $252.63M+31.6% | ||
| -$109.03M-13.1% | -$103.86M-7.5% | -$92.53M+13.1% | -$91.76M+16.3% | -$96.4M+11.1% | ||
| -33.9%+4.8pp | -33.7%+9.3pp | -30.9%+22.4pp | -33.4%+28.7pp | -38.7%+30.7pp | ||
| $3.53M-12.2% | $3.59M-14.3% | $3.66M-15.7% | $3.88M-8.0% | $4.02M-3.3% | ||
| —— | -$157K— | -$117.75K— | -$78.5K— | -$39.25K— | ||
| —— | —— | —— | —— | -$93.07M+8.9% | ||
| —— | —— | —— | —— | $229K+50.7% | ||
| -$102.47M-13.6% | -$95.57M-4.5% | -$84.58M+15.5% | -$84.15M+18.9% | -$90.19M+12.7% | ||
| -31.8%+4.4pp | -31%+9.7pp | -28.2%+21.9pp | -30.6%+28.1pp | -36.2%+29.9pp | ||
| -$1.82-7.7% | -$1.71+2.3% | -$1.52+22.1% | -$1.54+25.2% | -$1.69+20.3% | ||
| -$1.82-7.7% | -$1.71+2.3% | -$1.52+22.1% | -$1.54+25.2% | -$1.69+20.3% | ||
| 223.2M+6.0% | 221.6M+7.2% | 218.2M+8.1% | 214.5M+8.2% | 210.7M+9.9% | ||
| 223.2M+6.0% | 221.6M+7.2% | 218.2M+8.1% | 214.5M+8.2% | 210.7M+9.9% | ||
| -$102.71M-14.0% | -$95.65M-4.7% | -$84.52M+15.5% | -$84.29M+18.7% | -$90.08M+12.8% | ||
| $10.23M-3.0% | $12.02M+23.2% | $11.93M+10.2% | $11.82M+15.5% | $10.55M+13.3% | ||
| $322.02M+29.3% | $308.05M+37.2% | $299.91M+50.1% | $274.95M+55.7% | $249.12M+59.4% | ||
| -$109.03M-13.1% | -$103.86M-7.5% | -$92.53M+13.1% | -$91.76M+16.3% | -$96.4M+11.1% | ||
| -$102.38M-12.7% | -$97.47M-6.7% | -$86.4M+14.8% | -$85.92M+18.0% | -$90.88M+12.8% | ||
| -$102.38M-12.7% | -$97.47M-6.7% | -$86.4M+14.8% | -$85.92M+18.0% | -$90.88M+12.8% | ||
| -31.8%+4.7pp | -31.6%+9.1pp | -28.8%+21.9pp | -31.2%+28.1pp | -36.5%+30.2pp | ||
| -$109.03M-13.1% | -$103.86M-7.5% | -$92.53M+13.1% | -$91.76M+16.3% | -$96.4M+11.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is PROCEPT BioRobotics Corporation's revenue?
- PROCEPT BioRobotics Corporation (PRCT) generated $322.0M in revenue over the trailing twelve months, up 29.3% year over year.
- Is PROCEPT BioRobotics Corporation profitable?
- PROCEPT BioRobotics Corporation is not currently profitable: it reported a net loss of $102.5M over the trailing twelve months, a -31.8% net margin.
- What are PROCEPT BioRobotics Corporation's profit margins?
- Gross margin is 64.0% and operating margin is -33.9%, with a -31.8% net margin.
- What is PROCEPT BioRobotics Corporation's earnings per share?
- PROCEPT BioRobotics Corporation's diluted EPS over the trailing twelve months is $-1.82.
- Where does PROCEPT BioRobotics Corporation's income statement data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
